Public Release: 

2015 Ross Prize in Molecular Medicine

Harnessing cell signaling pathways to treat cancer

New York Academy of Sciences

EVENT: 2015 Ross Prize in Molecular Medicine: Harnessing Cell Signaling Pathways to Treat Cancer

Presented by The Feinstein Institute for Medical Research, Molecular Medicine, and The New York Academy of Sciences

DATE: Monday, June 8, 2015 | 10:00 AM - 3:30 PM

LOCATION: The New York Academy of Sciences, New York, NY


DESCRIPTION: The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine. The Prize recognizes biomedical scientists whose discoveries have changed the way medicine is practiced. It is awarded to scientists who have made a significant impact in the understanding of human disease pathogenesis and/or treatment and who hold significant promise for making even greater contributions to the general field of molecular medicine.

The 2015 Ross Prize in Molecular Medicine will be awarded to Dr. Lewis C. Cantley for his critical discoveries regarding signaling pathways in cancer cells. Dr. Cantley discovered the phosphoinositide 3-kinases (PI3K), which are critical for cell growth, proliferation, and survival. Following this discovery, he demonstrated that activity-enhancing mutations in PI3K were present in several types of human cancer, and he continued to investigate small molecule inhibitors of PI3K that are now approved for use in the treatment of cancer.

PRESS REGISTRATION: For complimentary press registration, contact Diana Friedman (; 212-298-8645)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.